(Reuters) – CVS Health Corp, best known for its national chain of drugstores, said on Thursday it had started offering clinical trial services to support drug developers with tasks like patient enrollment.
CVS said it had already collaborated with drug developers to help facilitate clinical trials for investigational COVID-19 vaccines and treatments, which the new business will now expand. (https://refini.tv/3fvQaTi)
(Reporting by Manojna Maddipatla in Bengaluru; Editing by Amy Caren Daniel)
